drugset / Trial / NCT01310673

Initiation of Allopurinol at First Medical Contact for Acute Attacks of Gout

NCT01310673

RandomizedParallel-groupQuadruple-blindTreatment

Summary

Medical teaching suggests allopurinol should not be initiated in the setting of an acute attack of gout, as rapid lowering of serum urate may exacerbate the attack. This study tests the hypothesis that there is no difference in patient reported daily pain or flair occurrences with early versus delayed institution of allopurinol during an acute gout attack.

Timeline

Start
1998-01
Primary completion
2009-07
Completion
2009-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Allopurinol Small molecule 300 mg Oral

Indications